Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin.
Topic:
Diabetes, dysglycaemia and metabolic syndrome
Speaker:
Professor D. McGuire (Dallas, US)
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Professor Darren Keith McGuire
University of Texas Southwestern Medical Center, Dallas (United States of America)
18
presentations
0
follower
Professor Jose Ramon Gonzalez Juanatey
University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
20
presentations
1
follower
Access the full session
Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin
Speakers:
Professor D. McGuire, Professor J. Gonzalez Juanatey
About the event
ESC 365 is supported by
